Developing Next-Generation in Vivo Cell and Gene Therapies
Bioverge - A podcast by The Bioverge Podcast

Categories:
David Johnson, founder and CEO of GigaMune, sits down with Neil to discuss his company's efforts to develop in vivo cell and gene therapies to treat cancer and autoimmune conditions.